Protocol Ledger

NCT07575672 · Phase III · RECRUITING

Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure

Interventional Phase III clinical trial protocol NCT07575672 sponsored by Second Affiliated Hospital, Zhejiang University, School of Medicine in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-10-09 Enrollment: 2,832 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07575672
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)2,832 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07575672
Protocol FieldVerified Registry Value
NCT IdentifierNCT07575672
Consolidated Lead SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment2,832 participants (ESTIMATED)
Registered Start Date2026-10-09
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI